<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               17 PATIENT COUNSELING INFORMATION<BR>               <BR>                  Advise patients to take metoprolol succinate extended-release tablets regularly and continuously, as directed, preferably with or immediately following meals. If a dose is missed, the patient should take only the next scheduled dose (without doubling it). Patients should not interrupt or discontinue metoprolol succinate extended-release tablets without consulting the physician.<BR>                  Advise patients (1) to avoid operating automobiles and machinery or engaging in other tasks requiring alertness until the patientâ€™s response to therapy with metoprolol succinate extended-release tablets has been determined; (2) to contact the physician if any difficulty in breathing occurs; (3) to inform the physician or dentist before any type of surgery that he or she is taking metoprolol succinate extended-release tablets.<BR>                  Heart failure patients should be advised to consult their physician if they experience signs or symptoms of worsening heart failure such as weight gain or increasing shortness of breath.<BR>                  Manufactured by:<BR>Watson Laboratories, Inc.<BR>Corona, CA 92880 USA<BR>                  Repackaged by:<BR><BR>                     Rebel Distributors Corp<BR>                     <BR>Thousand Oaks, CA 91320<BR>               <BR>               <BR>            <BR>         </P></DIV></HTML>